However, the most interesting finding from these studies was that the clinical manifestations of disease were also significantly influenced by mutational order: acquiring either TET2 or DNMT3A mutation prior to the JAK2 mutation resulted in a much higher frequency of ET rather than PV. This evidence concerns the gene JAK2 and acquired polycythemia vera.